Medtronic plc (MDT) Comparison with companies in other sectors?

Medtronic plc has a share price of 1.28B. You can analyze Medtronic plc (MDT) competitors across different market sectors through stock heatmaps.

What are MDT's NET and operating margins?

Medtronic plc (MDT) operating margin is around 0.18, and net profit margin is approximately 0.14 as of the latest reports.

In what way does MDT's earnings per share (EPS) trend reflect its financial momentum?

Medtronic plc (MDT) EPS is 3.61 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Medtronic plc is 24.85, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Medtronic plc?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Medtronic plc like P/E which is 24.74, P/B which is 2.40, and PEG which is 2.47. Compare them with sector averages to evaluate if the stock is priced fairly.

Medtronic plc

MDT•NYSE

Healthcare

Medical - Devices

$91.47

$1.86(2.07%)

Fundamental Analysis of Medtronic plc (MDT)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$3.61

P/E Ratio

24.85

ROE

0.10%

Net Margin

0.14%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$114.96B

Shares OutstandingTotal number of shares issued

$1.28B

Book Value/ShareNet worth per share

$37.63

Revenue/ShareAnnual revenue per share

$26.15

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$3.61

Net MarginNet income as percentage of revenue

13.90%

Operating MarginOperating income as percentage of revenue

17.76%

ROEReturn on shareholders' equity

9.62%

ROAReturn on total assets

5.09%

ROCEReturn on capital employed

7.56%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$4.04

Cash/ShareCash and equivalents per share

$6.99

FCF YieldFree cash flow as percentage of market cap

4.50%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$2.81

Dividend YieldAnnual dividend as percentage of stock price

3.13%

Financial Ratios Analysis data is not available for MDTFinancial Ratios Analysis details for MDT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for MDTSector Benchmarking details for MDT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Medtronic plc Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Medtronic plc. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Medtronic plc's unique business strengths and challenges.

Key Financial Metrics for Medtronic plc

For Medtronic plc, essential financial indicators include EPS 3.61, PE 24.85, and ROE 0.10. These key ratios reveal insights into Medtronic plc's profitability, valuation, and operational health. Understanding these metrics enables you to compare Medtronic plc with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Medtronic plc

Metrics like Net Margin 13.90% and ROA 5.09% shed light on how well Medtronic plc is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Medtronic plc can sustain its operations and continue growing in the future.

Valuation and Market Position of Medtronic plc

Using ratios such as P/B Ratio 2.40 and PEG Ratio 2.47, investors can assess whether Medtronic plc is appropriately valued based on its financials and growth potential. These figures, combined with Medtronic plc's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Medtronic plc

Financial health indicators, such as Debt/Equity Ratio 0.59 and Cash Flow $4.04, provide a snapshot of Medtronic plc's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Medtronic plc, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Medtronic plc

Investing in Medtronic plc based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Medtronic plc focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;